Test
Quidel™ Solana HSV 1+2/VZV Assay is multiplex in vitro diagnostic test for detection and differentiation of Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), and Varicella-zoster virus (VZV) nucleic acids isolated and purified from cutaneous or mucocutaneous swab specimens.
Includes | Package insert, Dilution buffer, Lysis buffer, Reaction tubes; Lyophilized Master Mix reagent |
---|---|
Content And Storage | 2°C to 8°C (No ice or cooling block required) |
Type | Solana HSV 1+2/VZV Starter Kit |
Sensitivity | Cutaneous: 100% (HSV-1), 92.3% (HSV-2), 100% (VZV); Mucocutaneous: 100% (HSV-1), 99.1% (HSV-2), 100% (VZV); Non categorized: 100% (HSV-1), 100% (HSV-2), 100% (VZV) |
Sample Type | Cutaneous or mucocutaneous lesion samples obtained from symptomatic patients |
Shelf Life | Up to 12 Months from DOM |
For Use With (Application) | Diagnosis of Herpes Simplex Virus (HSV) 1 and 2 and Varicella-zoster virus (VZV) |
Clia Complexity | Moderate (Prescription Use Only) |
Test Time | ≈50 min. |
Qualitative in vitro diagnostic test for direct detection and differentiation of herpes simplex virus type 1 and type 2 in cutaneous and mucocutaneous lesion specimens.
Ensure proper results and lab training for the Savanna™ HSV1+2 and VZV Assay
Form | Ready-to-Use (RTU) |
---|---|
Detectable Analytes | HSV |
CE Marker | CE-IVD |
Clia Complexity | Moderate (Waiver Pending) |
The Savanna HSV 1+2/VZV Assay is an automated, rapid multianalyte real-time PCR test intended for use with the Savanna Platform and approved for the simultaneous qualitative detection and differentiation of herpes simplex virus type 1, herpes simplex virus type 2 and varicella-zoster virus.
For qualitative detection and differentiation of Herpes simplex virus 1 and 2 (HSV1 and HSV2) nucleic acids isolated from cutaneous or mucocutaneous lesion of symptomatic patients
Carry out rapid detection and identification of HSV1 and HSV2 in cell cultures with this direct immunofluorescence assay.
For the qualitative and semiquantitative detection of human IgG antibodies to type 1 and type 2 Herpes Simplex virus
PathoDx™ and Herpes Typing Control Slide is used with Herpes immunofluorescent assays.
Quidel™ Solana HSV 1+2/VZV Assay is multiplex in vitro diagnostic test for detection and differentiation of Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), and Varicella-zoster virus (VZV) nucleic acids isolated and purified from cutaneous or mucocutaneous swab specimens.
Includes | One leased Solana Instrument, HSV 1+2/VZV Assay Kit (48 tests), Solana HSV 1+2/VZV Control Set, 95C Lysis heat block, Printer, Labels, Tray, three racks and stylus; Lyophilized Master Mix reagent |
---|---|
Content And Storage | 2°C to 8°C (No ice or cooling block required) |
Type | Solana HSV 1+2/VZV Starter Kit |
Sensitivity | Cutaneous: 100% (HSV-1), 92.3% (HSV-2), 100% (VZV); Mucocutaneous: 100% (HSV-1), 99.1% (HSV-2), 100% (VZV); Non categorized: 100% (HSV-1), 100% (HSV-2), 100% (VZV) |
Sample Type | Cutaneous or mucocutaneous lesion samples obtained from symptomatic patients |
Shelf Life | Up to 12 Months from DOM |
For Use With (Application) | Diagnosis of Herpes Simplex Virus (HSV) 1 and 2 and Varicella-zoster virus (VZV) |
Clia Complexity | Moderate (Prescription Use Only) |
Test Time | ≈50 min. |
Quidel Solana HSV 1+2/VZV Control Set for aid in diagnosis of Herpes Simplex Virus (HSV) 1 and 2 and Varicella-zoster virus (VZV).
Multiplex RT-PCR IVD detect/differentiate herpes simplex virus type 1 and 2, varicella-zoster virus nucleic acids isolated/purified from cutaneous/mucocutaneous specimens, FDA approved for use Applied Biosystems™ 7500 FastDx RT-PCR, QuantStudioDx RT-PCR, Cepheid™ SmartCycler™ II
This kit is an immunofluorescent test used for detection and typing of Herpes Simplex Virus I and II in direct clinical specimens and tissue cultures.
Molecular diagnostic external controls for use with Alethia HSV type-1 and type-2
Detects IgG antibodies to herpes simplex virus type 1 and/or type 2 in human serum
Detects IgM antibodies to herpes simplex virus type 1 and/or type 2 in human serum